Home | Welcome to Contract Pharma   
Last Updated Saturday, May 18 2013
Print RSS Feed

Breaking News

Related Searches: Financial Reports

April 20, 2007
Pfizer 1Q Revenues: $12.5 billion (+6%) 1Q Earnings: $3.4 billion (-16%) Comments: Worldwide pharmaceutical revenues grew 5% in the quarter to $11.6 billion. Revenue growth was driven by Lipitor, up 8% to $3.4 billion, Celebrex, up 22% t…  Read More »

April 20, 2007
Nabi Biopharmaceuticals has executed a definitive agreement to sell its Aloprim for Injection product to Bioniche Teoranta for $3.7 million. Bioniche Teoranta is based in Ireland and is part of Bioniche Pharma Group. The transaction, subject to custo…  Read More »

April 19, 2007
BioConvergence LLC is expanding its Bloomington, IN headquarters in an effort to better serve its pharma/biopharmaceutical clients. BioConvergence will add approximately 20,000 sq. ft. to its existing 50,000-sq.-ft. facility to accommodate its growin…  Read More »

April 19, 2007
Lexicon Genetics released data highlighting potential therapeutic targets related to its collaboration with Genentech. These target discoveries were made through the collaboration between the two companies that was initiated in December 2002 and expa…  Read More »

April 19, 2007
Merck 1Q Revenues: $5.8 billion (+7%) 1Q Earnings: $1.7 billion (+12%) Comments: Gardasil sales reached $365 million in the quarter. Key products -- including Singulair, Zetia, Vytorin and Januvia -- drove results in the quarter. Combined glo…  Read More »

April 18, 2007
Avanir Pharmaceuticals achieved positive results from its Phase III trial evaluating Zenvia, an NMDA antagonist and sigma-1 agonist, in diabetic neuropathic pain. The primary endpoint of the trial was based on the daily diary entries for the Pai…  Read More »

April 18, 2007
Abbott 1Q Revenues: $5.3 billion (15.5%) 1Q Earnings: $697.5 million (-19%) Comments: Worldwide pharmaceutical sales were $3.4 billion, up 16.6%. Humira grew to $289 million in sales, up $32.4. Earnings in the quarter excludes after-ta…  Read More »

April 18, 2007
The FDA has licensed Sanofi Pasteur's H5N1 vaccine, the first avian flu vaccine for humans. Sanofi Pasteur, in collaboration with the National Institutes of Health, submitted a BLA to the FDA for the vaccine. The licensure is the first step in achiev…  Read More »

April 17, 2007
GE Healthcare, a unit of General Electric Co., has acquired Wave Biotech LLC, a supplier of disposable manufacturing technologies for the biopharmaceutical industry. The acquisition of Wave Biotech LLC, including its subsidiary Wave Europe Pvt. Ltd.,…  Read More »

April 17, 2007
Patheon plans to restructure its network of six pharmaceutical manufacturing facilities in southern ON, Canada as part of its strategy to focus on developing and manufacturing prescription pharmaceutical products and to improve profitability. Th…  Read More »

April 17, 2007
Johnson & Johnson 1Q Revenues: $15 billion (+16%) 1Q Earnings: $2.6 billion (-22%) Comments: Worldwide Pharmaceutical sales were $6.2 billion in the quarter, up 11%. Sales growth reflects the strong performance of Topamax, Levaquin,…  Read More »

April 17, 2007
Merck has submitted a sBLA for Gardasil to the FDA to update the labeling to include efficacy data showing protection against additional cervical cancer causing HPV types responsible for more than 10% of cervical cancers, vaginal and vulvar, and data…  Read More »

April 16, 2007
Millipore Corp. is the first company to integrate Radio Frequency Identification (RFID) technology with filtration products used to manufacture biopharmaceutical drugs. The new RFID capability will be branded as SMART Technology and will be introduce…  Read More »

April 16, 2007
Galapagos' BioFocus DPI service division has signed two new collaborations with Ono Pharmaceutical Co. Ltd., building on the successful relationship between Ono and DPI, which began in 2004. Under the first collaboration, BioFocus DPI will use select…  Read More »

April 16, 2007
Lilly 1Q Revenues: $4.2 billion (+14%) 1Q Earnings: $508.7 million (-39%) Comments: Alimta, Byetta, Cialis, Cymbalta, Forteo, Strattera, Symbyax, Xigris and Yentreve, collectively grew 57% to $1.3 billion, and accounted for 30% of total…  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:

Follow Contract Pharma On